Table 1.
The characteristics and laboratory data of patients and controls.
| PMOP group | Control group | P | |
|---|---|---|---|
| Number | 480 | 170 | |
| Age (years) | 58.55 ± 3.55 | 58.47 ± 3.52 | 0.813 |
| Weight (kg) | 59.43 ± 4.92 | 59.33 ± 4.63 | 0.823 |
| Height (m) | 1.54 ± 0.05 | 1.55 ± 0.05 | 0.277 |
| BMI (kg/m2) | 24.92 ± 1.66 | 24.73 ± 1.63 | 0.190 |
| BMD (g/m2) | 0.817 ± 0.073 | 0.997 ± 0.073 | <0.001 |
| T-score | −3.196 ± 0.599 | −1.638 ± 0.542 | <0.001 |
| Estradiol (pmol/mL) | 36.63 ± 15.23 | 38.59 ± 16.08 | 0.157 |
| N-MID-OT (ng/mL) | 16.49 ± 5.96 | 16.19 ± 5.81 | 0.564 |
| 25(OH)D (ng/mL) | 14.68 ± 4.93 | 14.74 ± 4.76 | 0.893 |
| CTX (ng/mL) | 0.410 ± 0.086 | 0.323 ± 0.065 | <0.001 |
| PINP (ng/mL) | 51.69 ± 9.05 | 46.03 ± 10.10 | 0.005 |
| β-catenin (pg/mL) | 26.26 ± 14.81 | 39.33 ± 5.47 | <0.001 |
| Sclerostin (pmol/L) | 38.79 ± 7.43 | 52.86 ± 6.69 | <0.001 |
| OPG (pg/mL) | 155.07 ± 91.06 | 157.92 ± 71.67 | 0.679 |
| RANKL (pmol/L) | 158.10 ± 94.53 | 116.03 ± 54.89 | <0.001 |
| Ratio of RANKL/OPG | 1.60 ± 1.76 | 0.87 ± 0.45 | <0.001 |
Data for continuous variables are presented as mean ± SD.